Luxena Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Luxena Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase I PK and Safety Study of Ondansetron Inhalation Powder (NCT07498751) | Luxena Pharmaceuticals, Inc. | 2025-03-13 |
Track Luxena Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.